Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haitong Securities is a leading Chinese financial services provider headquartered in Shanghai. Established in 1988, it offers a comprehensive suite of services including securities brokerage, asset management, and investment banking. The firm is a major facilitator in the life sciences sector, frequently acting as a lead underwriter for biotechnology and healthcare IPOs on the STAR Market and Hong Kong Stock Exchange. Additionally, its private equity arm, Haitong Capital, actively invests in innovative medical technology and pharmaceutical startups. The company is dual-listed on the Shanghai and Hong Kong stock exchanges and maintains a significant international presence through its subsidiaries. It is consistently ranked as one of the largest securities firms in China by total assets and net capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haitong Securities.